NMPA published the “Clinical Evaluation Exempt Draft Catalog for Medical Devices” and “Clinical Evaluation Exempt Draft Catalog for In Vitro Diagnostics” on April 30, 2026. Feedbacks need to be submitted by May 29, 2026. It proposes to newly-include 11 Class III medical devices and 66 Class III IVDs into the exemption list. Implementing risk-based clinical […]

The post 11 Class III Devices and 66 IVDs to be Newly Exempted from Clinical Trial; Feedback until May 29 appeared first on China Med Device.

​